» Articles » PMID: 39409997

Efficacy and Safety of Fluorescence-Guided Surgery Compared to Conventional Surgery in the Management of Colorectal Cancer: A Systematic Review and Meta-Analysis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Oct 16
PMID 39409997
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The use of fluorescence agents and imaging systems is a promising adjunct in the surgical management of colorectal cancer. This systematic review and meta-analysis aimed to assess the safety and efficacy of fluorescence-guided surgery in the management of colorectal cancer, with a comparison to conventional (non-fluorescence-guided) surgery.

Methods: A literature search of MEDLINE, Embase, Emcare, and CINAHL databases was performed for studies that reported data on the outcomes of fluorescence-guided surgery, with or without a comparison group undergoing conventional surgery, for colorectal cancer between January 2000 and January 2024. A meta-analysis was performed using random-effect models, and between-study heterogeneity was assessed.

Results: 35 studies of 3217 patients with colorectal cancer were included: 26 studies (964 patients) reported on fluorescence-guided surgery and 9 studies (2253 patients) reported on fluorescence versus conventional surgery. The weighted mean of the cancer detection rate of fluorescence-guided surgery was 71% (95% CI 0.55-0.85), with no significant difference in lymph node yield ratio (WMD -0.04; 95% CI -0.10-0.02; = 0.201) between fluorescence and conventional surgery groups. There was a significantly lower blood loss (WMD -4.38; 95% CI -7.05--1.70; = 0.001) and complication rate (WMD -0.04; 95% CI -0.07-0.00; = 0.027) in the fluorescence-guided surgery group, with a potentially lower anastomotic leak rate (WMD -0.05; 95% CI -0.10-0.01; = 0.092).

Conclusions: Fluorescence-guided surgery is a safe and effective approach in the management of colorectal cancer, potentially reducing blood loss and complications. Further randomised controlled trials are required comparing fluorescence-guided surgery with conventional surgery to determine its prognostic benefit and where it should precisely fit within the management pathway of colorectal cancer.

Citing Articles

Indocyanine Blue (ICB) as a Functional Alternative to Indocyanine Green (ICG) for Enhanced 700 nm NIR Imaging.

Yamashita A, Jang P, Bao K, Kashiwagi S, Frangioni J, Choi H Int J Mol Sci. 2025; 25(24.

PMID: 39769309 PMC: 11676035. DOI: 10.3390/ijms252413547.

References
1.
Liang Y, Zhang N, Wang M, Liu Y, Ma L, Wang Q . Distributions and Trends of the Global Burden of Colorectal Cancer Attributable to Dietary Risk Factors over the Past 30 Years. Nutrients. 2024; 16(1). PMC: 10780867. DOI: 10.3390/nu16010132. View

2.
Kim H, Choi G, Park J, Park S, Cho S, Seo A . S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection. Surg Endosc. 2019; 34(1):469-476. DOI: 10.1007/s00464-019-06830-x. View

3.
Hren R, Sersa G, Simoncic U, Milanic M . Imaging perfusion changes in oncological clinical applications by hyperspectral imaging: a literature review. Radiol Oncol. 2022; 56(4):420-429. PMC: 9784371. DOI: 10.2478/raon-2022-0051. View

4.
Giraudeau C, Moussaron A, Stallivieri A, Mordon S, Frochot C . Indocyanine green: photosensitizer or chromophore? Still a debate. Curr Med Chem. 2013; 21(16):1871-97. DOI: 10.2174/0929867321666131218095802. View

5.
Zedan A, Salah T . Total mesorectal excision for the treatment of rectal cancer. Electron Physician. 2016; 7(8):1666-72. PMC: 4725422. DOI: 10.19082/1666. View